The University Health Network, where "above all else the needs of patients come first", encompasses Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and the Michener Institute of Education. The breadth of research, the complexity of the cases treated, and the magnitude of its educational enterprise has made UHN a national and international resource for patient care, research and education. With a long tradition of ground breaking firsts and a purpose of "Transforming lives and communities through excellence in care, discovery and learning", the University Health Network (UHN), Canada's largest research teaching hospital, brings together over 16,000 employees, more than 1,200 physicians, 8,000+ students, and many volunteers. UHN is a caring, creative place where amazing people are amazing the world.
Union: Non-Union
Site: Princess Margaret Cancer Centre
Department: Cancer Biology & Imaging Program
Reports to: Principal Investigator
Work Model: On-Site
Grade: V0:90
Hours: 37.5 hours per week
Salary: $60,000 minimum, annually: To commensurate with experience and consistent with UHN compensation policy
Shifts: Monday - Friday
Status: Temporary Full Time (12-months, with option to extend beyond 1 year and convert to permanent position)
Closing Date: December 31, 2024 (repost)
Position Summary
The DaCosta Research Lab at the Princess Margaret Cancer Centre (PMCC) (http://dacostalab.ca/) is currently seeking a Postdoctoral Fellow to join our preclinical pancreatic cancer research team.
The successful applicant will be part of a research group that uses intravital fluorescence microscopy imaging in live animals to study pancreatic cancer initiation, biology, progression, and response to novel radiotherapeutic treatment strategies using advanced animal models of cancer, within the mouse pancreas. The successful applicant will help to study the pancreatic tumor microenvironment in an orthotopic setting, with a focus on tumor vasculature, hypoxia, immune cells, stroma, and other key aspects in vivo. An important area to investigate when in this role will include the study of novel radio-sensitizers and their role in pancreatic treatment response. A key additional focus area will be on the use of immune- and cell therapies for treatment of pancreatic cancer.
The successful applicant will also collaborate extensively with other labs across UHN, as well as external collaborators. The position status is temporary full-time (1 year) with the potential to extend to permanent full-time based on the candidate's performance and compatibility with the research team and lab objectives. The ideal candidate will have a clear career plan to become a principal investigator or independent scientist seeking an academic faculty position.
Primary Duties
Why join UHN?
In addition to working alongside some of the most talented and inspiring healthcare professionals in the world, UHN offers a wide range of benefits, programs and perks. It is the comprehensiveness of these offerings that makes it a differentiating factor, allowing you to find value where it matters most to you, now and throughout your career at UHN.
Current UHN employees must have successfully completed their probationary period, have a good employee record along with satisfactory attendance in accordance with UHN's attendance management program, to be eligible for consideration.
All applications must be submitted before the posting close date.
UHN uses email to communicate with selected candidates. Please ensure you check your email regularly.
Please be advised that a Criminal Record Check may be required of the successful candidate. Should it be determined that any information provided by a candidate be misleading, inaccurate or incorrect, UHN reserves the right to discontinue with the consideration of their application.
UHN is an equal opportunity employer committed to an inclusive recruitment process and workplace. Requests for accommodation can be made at any stage of the recruitment process. Applicants need to make their requirements known.
We thank all applicants for their interest, however, only those selected for further consideration will be contacted.